First patient with bone marrow cancer treated with CAR-T in Denmark
CITCO has now treated its first myeloma patient with CAR-T cells
CITCO has now treated its first multiple myeloma patient with CAR-T cells in a phase III clinical study: CARTITUDE-5.
An important milestone for CITCO has thus been reached.
The patient will also be the first patient with bone marrow cancer to be treated with the new promising treatment in Denmark.
An important milestone for CITCO has thus been reached.
The patient will also be the first patient with bone marrow cancer to be treated with the new promising treatment in Denmark.